Literature DB >> 24129803

Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years.

Patrick Cherin1, Elena Voronska, Nadia Fraoucene, Christophe de Jaeger.   

Abstract

BACKGROUND AND AIMS: Sarcopenia has been indicated as a reliable marker of frailty and poor prognosis among the oldest individuals. There are only few data on sarcopenia in healthy general population. We evaluated the prevalence of sarcopenia and its association with functional and clinical status in a population of healthy ambulatory subjects over 45 years living at home, in Paris (France).
METHODS: This study was conducted selecting all ambulatory participants (n = 1,445) aged 45 years and older from October 2008 to September 2011, consulting in the Institute of Physiology (Institut de Jaeger) from Paris (France) for a functional and muscular evaluation, and did not have limitations to moderate physical exercise. All were healthy people. All subjects performed a medical examination, associated with evaluation of muscle mass (body composition assessment using dual-energy X-ray absorptiometry) and of muscle function (by hand grip strength). Diagnosis of sarcopenia required the documentation of low muscle mass with low muscle strength according to the current international consensus definition of sarcopenia.
RESULTS: From 1,421 participants (553 males and 868 females) definitively enrolled, 221 subjects (135 females and 86 males) (15.5 %) were identified as sarcopenic. Results from multivariate logistic regression models showed that sarcopenia was inversely associated with BMI with those participants with BMI higher than 22 kg/m(2) showing a lower risk of sarcopenia relative to those with BMI less than 21 kg/m(2) (OR 0.72; 95 % CI 0.60-0.91). Similarly, probability of sarcopenia was lower among subjects involved in leisure physical activities for 3 h or more per week (OR 0.45; 95 % CI 0.24-0.93). According to the category of age [45-54; 55-64; 65-74; 75-84 and 85 years or more], the prevalence of sarcopenia in women increase from 9.1; 12.7; 14.5; 19.4; to 33.3 %, respectively. For the men, the percentage of sarcopenia increase with aging from 8.6; 15.6; 13.6; 63.8 to 45.5 %, respectively.
CONCLUSIONS: The present study suggests that among healthy ambulatory subjects over 45 years living at home, sarcopenia is frequent, even to the youngest subjects of the studied population, taking place from 9 % from 45 years, until 64.3 % for the subjects over 85 years. Our findings support the hypothesis that muscle mass and function are associated with BMI and physical activity, whatever the age of the subject.

Entities:  

Mesh:

Year:  2013        PMID: 24129803     DOI: 10.1007/s40520-013-0132-8

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  29 in total

1.  Financial impact of sarcopenia on hospitalization costs.

Authors:  A S Sousa; R S Guerra; I Fonseca; F Pichel; S Ferreira; T F Amaral
Journal:  Eur J Clin Nutr       Date:  2016-05-11       Impact factor: 4.016

2.  Association of body mass index with all-cause mortality in patients with diabetes: a systemic review and meta-analysis.

Authors:  Hsiao-Wen Chang; Yi-Hwei Li; Chang-Hsun Hsieh; Pang-Yen Liu; Gen-Min Lin
Journal:  Cardiovasc Diagn Ther       Date:  2016-04

Review 3.  Practical Considerations for Body Composition Assessment of Adults with Class II/III Obesity Using Bioelectrical Impedance Analysis or Dual-Energy X-Ray Absorptiometry.

Authors:  Carlene A Johnson Stoklossa; Mary Forhan; Raj S Padwal; Maria Cristina Gonzalez; Carla M Prado
Journal:  Curr Obes Rep       Date:  2016-12

4.  Peak muscle mass in young men and sarcopenia in the ageing male.

Authors:  M Frost; T L Nielsen; K Brixen; M Andersen
Journal:  Osteoporos Int       Date:  2014-11-22       Impact factor: 4.507

5.  Fourteen days of bed rest induces a decline in satellite cell content and robust atrophy of skeletal muscle fibers in middle-aged adults.

Authors:  Emily J Arentson-Lantz; Kirk L English; Douglas Paddon-Jones; Christopher S Fry
Journal:  J Appl Physiol (1985)       Date:  2016-01-21

6.  Influence of sarcopenia on bone health parameters in a group of eumenorrheic obese premenopausal women.

Authors:  Emneh Hammoud; Hechmi Toumi; Christophe Jacob; Antonio Pinti; Eric Lespessailles; Rawad El Hage
Journal:  J Bone Miner Metab       Date:  2019-12-03       Impact factor: 2.626

Review 7.  Sarcopenia in patients with colorectal cancer: A comprehensive review.

Authors:  Omar Vergara-Fernandez; Mario Trejo-Avila; Noel Salgado-Nesme
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

8.  Sarcopenia and length of hospital stay.

Authors:  A S Sousa; R S Guerra; I Fonseca; F Pichel; T F Amaral
Journal:  Eur J Clin Nutr       Date:  2015-12-16       Impact factor: 4.016

9.  Protein Source and Quality for Skeletal Muscle Anabolism in Young and Older Adults: A Systematic Review and Meta-Analysis.

Authors:  Paul T Morgan; Dane O Harris; Ryan N Marshall; Jonathan I Quinlan; Sophie J Edwards; Sophie L Allen; Leigh Breen
Journal:  J Nutr       Date:  2021-07-01       Impact factor: 4.798

10.  Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran.

Authors:  Ali Darvishi; Mohsen Rezaei Hemami; Gita Shafiee; Rajabali Daroudi; Mahsa Mohseni; Farkhondeh Hosseini Shekarabi; Ramin Heshmat
Journal:  BMC Public Health       Date:  2021-05-17       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.